Non-coding RNAs: The cancer X factor.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed.

1. Review of possible mechanisms of radiotherapy resistance in cervical cancer.Frontiers in oncology · 2023
   Review
2. The Role of LncRNAs in the Regulation of Radiotherapy Sensitivity in Cervical Cancer.Frontiers in oncology · 2022
   Review
3. LncRNA LEF1-AS1 promotes metastasis of prostatic carcinoma via the Wnt/β-catenin pathway.Cancer cell international · 2020
   Article
4. The diagnostic value of miR-92a, -143, and -145 expression levels in patients with colorectal adenocarcinoma from Romania.Medicine · 2020
   Observational
5. Research Progress on Long Non-Coding RNA and Radiotherapy.Medical science monitor : international medical journal of experimental and clinical research · 2019
   Review
6. RPSAP52 lncRNA is overexpressed in pituitary tumors and promotes cell proliferation by acting as miRNA sponge for HMGA proteins.Journal of molecular medicine (Berlin, Germany) · 2019
   Article
7. AFAP1-AS1: A novel oncogenic long non-coding RNA in human cancers.Cell proliferation · 2018
   Review
8. lncRNA MALAT1, HOTTIP and PVT1 as predictors for predicting the efficacy of GEM based chemotherapy in first-line treatment of pancreatic cancer patients.Oncotarget · 2017
   Article
9. The long non-coding RNA LINC01013 enhances invasion of human anaplastic large-cell lymphoma.Scientific reports · 2017
   Article
10. Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer cells.Cell death discovery · 2017
    Article
11. High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma.Journal of translational medicine · 2015
    Article
12. Long non-coding RNA derived miR-205-5p modulates human endometrial cancer by targeting PTEN.American journal of translational research · 2015
    Article

Corrections and comments

• Comment on
  Xist RNA is a potent suppressor of hematologic cancer in mice.2013

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.